Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VONOPRAZAN vs VORTIOXETINE HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VONOPRAZAN vs VORTIOXETINE HYDROBROMIDE: Safety Overview

Metric VONOPRAZAN VORTIOXETINE HYDROBROMIDE
Total FAERS Reports 2,019 13,705
Deaths Reported 73 400
Death Rate 3.6% 2.9%
Hospitalizations 342 1,741
Average Patient Age 63.6 yrs 48.8 yrs
% Female Patients 65.3% 69.5%
FDA Approval Date Nov 1, 2023 Sep 30, 2013
Manufacturer Phathom Pharmaceuticals Inc. Takeda Pharmaceuticals America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription